Biotech boosters win big in both HASC, SASC defense policy bills for FY26
Both the House and Senate Armed Services Committees voted to streamline Pentagon procurement of biologically-derived materials, from first aid treatments to novel explosives.
Sen. Todd Young
Congressional biotech commission calls for $15B over 5 years to catch up to China
Over $1 billion would pass through the Pentagon, researching shelf-stable blood for casualties, new lubricants for engines, more powerful explosives, and more. Commission Chairman Sen. Todd Young hopes to get the first funds in the 2026 NDAA.